BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND TFRC, P02786, 7037, ENSG00000072274, TFR1, CD71
31 results:

  • 1. Orexin-A mediates glioblastoma proliferation inhibition by increasing ferroptosis triggered by unstable iron pools and GPX4 depletion.
    Huan R; Zhang J; Yue J; Yang S; Han G; Cheng Y; Tan Y
    J Cell Mol Med; 2024 May; 28(9):e18318. PubMed ID: 38685674
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. H-ferritin-nanocaged gadolinium nanoparticles for ultra-sensitive MR molecular imaging.
    Zhang J; Yuan C; Kong L; Zhu F; Yuan W; Zhang J; Hong J; Deng F; Chen Q; Chen C; Wang T; Zuo Z; Liang M
    Theranostics; 2024; 14(5):1956-1965. PubMed ID: 38505606
    [No Abstract]    [Full Text] [Related]  

  • 3. Adaptive design of mRNA-loaded extracellular vesicles for targeted immunotherapy of cancer.
    Dong S; Liu X; Bi Y; Wang Y; Antony A; Lee D; Huntoon K; Jeong S; Ma Y; Li X; Deng W; Schrank BR; Grippin AJ; Ha J; Kang M; Chang M; Zhao Y; Sun R; Sun X; Yang J; Chen J; Tang SK; Lee LJ; Lee AS; Teng L; Wang S; Teng L; Kim BYS; Yang Z; Jiang W
    Nat Commun; 2023 Oct; 14(1):6610. PubMed ID: 37857647
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Transferrin receptor 1 targeted nanomedicine for brain tumor therapy.
    Li J; Zhang Z; Zhang B; Yan X; Fan K
    Biomater Sci; 2023 May; 11(10):3394-3413. PubMed ID: 36847174
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. brain-Targeted HFn-Cu-REGO Nanoplatform for Site-Specific Delivery and Manipulation of Autophagy and Cuproptosis in Glioblastoma.
    Jia W; Tian H; Jiang J; Zhou L; Li L; Luo M; Ding N; Nice EC; Huang C; Zhang H
    Small; 2023 Jan; 19(2):e2205354. PubMed ID: 36399643
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A role for ceruloplasmin in the control of human glioblastoma cell responses to radiation.
    Roy C; Avril S; Legendre C; Lelièvre B; Vellenriter H; Boni S; Cayon J; Guillet C; Guilloux Y; Chérel M; Hindré F; Garcion E
    BMC Cancer; 2022 Aug; 22(1):843. PubMed ID: 35918659
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Re-engineering the inner surface of ferritin nanocage enables dual drug payloads for synergistic tumor therapy.
    Wang Z; Zhao Y; Zhang S; Chen X; Sun G; Zhang B; Jiang B; Yang Y; Yan X; Fan K
    Theranostics; 2022; 12(4):1800-1815. PubMed ID: 35198074
    [No Abstract]    [Full Text] [Related]  

  • 8. Integrin α
    Huang CW; Chuang CP; Chen YJ; Wang HY; Lin JJ; Huang CY; Wei KC; Huang FT
    J Nanobiotechnology; 2021 Jun; 19(1):180. PubMed ID: 34120610
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Barcoded oligonucleotides ligated on RNA amplified for multiplexed and parallel in situ analyses.
    Liu S; Punthambaker S; Iyer EPR; Ferrante T; Goodwin D; Fürth D; Pawlowski AC; Jindal K; Tam JM; Mifflin L; Alon S; Sinha A; Wassie AT; Chen F; Cheng A; Willocq V; Meyer K; Ling KH; Camplisson CK; Kohman RE; Aach J; Lee JH; Yankner BA; Boyden ES; Church GM
    Nucleic Acids Res; 2021 Jun; 49(10):e58. PubMed ID: 33693773
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Development of a gene expression-based prognostic signature for IDH wild-type glioblastoma.
    Johnson RM; Phillips HS; Bais C; Brennan CW; Cloughesy TF; Daemen A; Herrlinger U; Jenkins RB; Lai A; Mancao C; Weller M; Wick W; Bourgon R; Garcia J
    Neuro Oncol; 2020 Dec; 22(12):1742-1756. PubMed ID: 32897363
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment.
    Liu W; Lin Q; Fu Y; Huang S; Guo C; Li L; Wang L; Zhang Z; Zhang L
    J Control Release; 2020 Jul; 323():191-202. PubMed ID: 31838201
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Engineered antibodies: new possibilities for brain PET?
    Sehlin D; Syvänen S;
    Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2848-2858. PubMed ID: 31342134
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genome-wide Integrative Analysis of Zika-Virus-Infected Neuronal Stem Cells Reveals Roles for MicroRNAs in Cell Cycle and Stemness.
    Dang JW; Tiwari SK; Qin Y; Rana TM
    Cell Rep; 2019 Jun; 27(12):3618-3628.e5. PubMed ID: 31216479
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Elucidation and Structural Modeling of cd71 as a Molecular Target for Cell-Specific Aptamer Binding.
    Wu X; Liu H; Han D; Peng B; Zhang H; Zhang L; Li J; Liu J; Cui C; Fang S; Li M; Ye M; Tan W
    J Am Chem Soc; 2019 Jul; 141(27):10760-10769. PubMed ID: 31185171
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Detection of circulating tumour cell clusters in human glioblastoma.
    Krol I; Castro-Giner F; Maurer M; Gkountela S; Szczerba BM; Scherrer R; Coleman N; Carreira S; Bachmann F; Anderson S; Engelhardt M; Lane H; Evans TRJ; Plummer R; Kristeleit R; Lopez J; Aceto N
    Br J Cancer; 2018 Aug; 119(4):487-491. PubMed ID: 30065256
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Glioma targeting peptide modified apoferritin nanocage.
    Zhai M; Wang Y; Zhang L; Liang M; Fu S; Cui L; Yang M; Gong W; Li Z; Yu L; Xie X; Yang C; Yang Y; Gao C
    Drug Deliv; 2018 Nov; 25(1):1013-1024. PubMed ID: 29726297
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Gallium Maltolate Disrupts Tumor Iron Metabolism and Retards the Growth of Glioblastoma by Inhibiting Mitochondrial Function and Ribonucleotide Reductase.
    Chitambar CR; Al-Gizawiy MM; Alhajala HS; Pechman KR; Wereley JP; Wujek R; Clark PA; Kuo JS; Antholine WE; Schmainda KM
    Mol Cancer Ther; 2018 Jun; 17(6):1240-1250. PubMed ID: 29592883
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.
    Rosager AM; Sørensen MD; Dahlrot RH; Hansen S; Schonberg DL; Rich JN; Lathia JD; Kristensen BW
    PLoS One; 2017; 12(8):e0182954. PubMed ID: 28837569
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. N-(p-coumaroyl) serotonin inhibits glioblastoma cells growth through triggering S-phase arrest and apoptosis.
    Lazari D; Alexiou GA; Markopoulos GS; Vartholomatos E; Hodaj E; Chousidis I; Leonardos I; Galani V; Kyritsis AP
    J Neurooncol; 2017 May; 132(3):373-381. PubMed ID: 28365838
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Quantitative proteomics reveals the novel co-expression signatures in early brain development for prognosis of glioblastoma multiforme.
    Yu X; Feng L; Liu D; Zhang L; Wu B; Jiang W; Han Z; Cheng S
    Oncotarget; 2016 Mar; 7(12):14161-71. PubMed ID: 26895104
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.